REV-ERBα/β Targeting Transcriptionally Reprograms HIV-Infected CD4 + T-Cells for Increased Viral Reactivation but Limited Virion Spread
Abstract
SUMMARY: The circadian clock repressors REV-ERBα/β control rhythmic gene expression and inhibit HIV-1 transcription. Whether REV-ERBα/β modulate the HIV-1 replication cycle beyond transcription remains unknown. Here, we demonstrate that memory CD4 + T-cells predominantly express the REV-ERBβ isoform ex vivo and that T-cell receptor (TCR) triggering downregulates both REV-ERBα/β expression, with levels of REV-ERBα/β mRNA being lower in ART-treated people with HIV (PWH) receiving antiretroviral therapy (ART) compared to people without HIV (PWoH) before/after TCR triggering. In single-round infection, the REV-ERBα/β antagonist SR8278 facilitated HIV-1 reverse transcription, integration, and intracellular HIV-p24 expression, but limited virion release. Moreover, SR8278 downregulated CCR5 mRNA expression, inhibited R5-tropic HIV-1 replication in vitro, and limited viral outgrowth in CD4 + T-cells from ART-treated PWH. Finally, genome-wide RNA-sequencing and functional validations revealed HIV-1 restriction/dependency factors that represent novel putative REV-ERBα/β targets. Thus, pharmacological inhibition of REV-ERBα/β uniquely combines a latency reversal activity with the inhibition of progeny virion spread.
Abstract Figure: Graphical Abstract
How strong is the evidence?
Evidence Hub reads this as a preprint, done in cell cultures (in vitro), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.